Professor Sean Tu Publishes in Nature Biotechnology

West Virginia College of Law professor  S. Sean Tu recently published a new article in Nature Biotechnology The article, titled& "Biologic patent challenges under the America Invests Act," is co-authored by Professor Tu with Victor L. Van de Wiele and Aaron Kesselheim, both of the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital.  It was published online by the journal on March 15, 2024.

An image with the title of the article, the journal name, and a brief description of the article.

New Citations to WVU Law Scholarship, October to December 2023

The scholarship of West Virginia University College of Law faculty members is frequently cited as authority in numerous legal disciplines. The following is a list of faculty authored works cited and made available on Westlaw Precision between October 1, 2023 and December 31, 2023.

Research Repository Update: January 2024

During January 2024, the contents of the  WVU College of Law community in the Research Repository @ WVU had 16,542 new full-text downloads of the 5,790 total works archived in our collections. Readers came from 1,267 different institutions across 149 different countries and territories. This brings the total full-text downloads of scholarship from the College of Law collections to 638,961.

Law faculty scholarship was downloaded a total of 4,708 times in January 2024. The most downloaded articles from the  faculty scholarship collection last month are:

Professor Sean Tu Publishes New Research Letter in JAMA

West Virginia College of Law professor  S. Sean Tu recently published a new opinion piece in JAMA. The article, titled  "Patents on Risk Evaluation and Mitigation Strategies for Prescription Drugs and Generic Competition," is co-authored by Professor Tu with Ameet Sarpatwari, PhD, Sajeev Kohli, and Aaron S. Kesselheim, MD, JD, MPH, all of the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital.  It was published online by the journal on February 22, 2024.

The article discusses the impact of patents held by manufacturers on risk evaluation and mitigation strategies or "REMS."  REMS may be required by the FDA to mitigate risks associated with certain prescription drugs.  Professor Tu and co-authors discuss the prevalence of REMS patents and their effect on delaying generic competition.

Research Repository Update: December 2023

During December 2023, the contents of the  WVU College of Law community in the Research Repository @ WVU had 15,239 new full-text downloads of the 5,790 total works archived in our collections. Readers came from 1,106 different institutions across 154 different countries and territories. This brings the total full-text downloads of scholarship from the College of Law collections to 623,332.

Law faculty scholarship was downloaded a total of 4,072 times in December 2023. The most downloaded articles from the  faculty scholarship collection last month are: